bioRxiv : the preprint server for biology

Improving Nme2Cas9 and Nme2SmuCas9 Gene Editing Proteins and Base Editors

Updated

Abstract

Adenine and cytosine base editors could correct approximately 30% of human pathogenic variants.

  • Base editors enable precise conversions of A:T-to-G:C and C:G-to-T:A base pairs.
  • Therapeutic use of base editors is limited by factors such as PAM availability and accuracy.
  • Nme2Cas9 and its derivatives have been developed to enhance editing near NCC PAMs.
  • Engineering efforts have yielded base editors with improved activity and vector compatibility.
  • Editing and specificity profiles of the enhanced variants were defined using paired guide-target libraries.

Simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free